Acquisition of multidrug resistance transposon Tn6061 and IS6100-mediated large chromosomal inversions in Pseudomonas aeruginosa clinical isolates

Microbiology
Sébastien CoyneMarc Galimand

Abstract

Pseudomonas aeruginosa is a major human opportunistic pathogen, especially for patients in intensive care units or with cystic fibrosis. Multidrug resistance is a common feature of this species. In a previous study we detected the ant(4')-IIb gene in six multiresistant clinical isolates of P. aeruginosa, and determination of the environment of the gene led to characterization of Tn6061. This 26 586 bp element, a member of the Tn3 family of transposons, carried 10 genes conferring resistance to six drug classes. The ant(4')-IIb sequence was flanked by directly repeated copies of ISCR6 in all but one of the strains studied, consistent with ISCR6-mediated gene acquisition. Tn6061 was chromosomally located in six strains and plasmid-borne in the remaining isolate, suggesting horizontal acquisition. Duplication-insertion of IS6100, that ended Tn6061, was responsible for large chromosomal inversions. Acquisition of Tn6061 and chromosomal inversions are further examples of intricate mechanisms that contribute to the genome plasticity of P. aeruginosa.

References

Jan 1, 1984·Molecular & General Genetics : MGG·S Mötsch, R Schmitt
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·S R PartridgeR M Hall
Jan 25, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Delphine GirlichPatrice Nordmann
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·Stefana SabtchevaThierry Lambert
Aug 19, 2003·Journal of Bacteriology·Daniel AubertPatrice Nordmann
Jan 2, 2004·Journal of Bacteriology·Jens KlockgetherBurkhard Tümmler
Jun 25, 2005·Bioinformatics·Tim J CarverJulian Parkhill
Dec 15, 2005·Journal of Bacteriology·Sandeep TamberRobert E W Hancock
Jan 18, 2006·PLoS Genetics·Pierre-Edouard FournierJean-Michel Claverie
Jun 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·Mark A TolemanTimothy R Walsh
Aug 9, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert A Bonomo, Dora Szabo
Jan 31, 2007·Antimicrobial Agents and Chemotherapy·H W StokesRuth M Hall
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kalai MatheeStephen Lory
May 1, 2008·Antonie van Leeuwenhoek·Sonia L RiveraCarlos Cervantes
Jul 30, 2008·Antimicrobial Agents and Chemotherapy·Thierry NaasPatrice Nordmann
Jul 30, 2008·Antimicrobial Agents and Chemotherapy·Mark A Toleman, Timothy R Walsh
Nov 26, 2008·Journal of Bacteriology·Alexandro Rodríguez-Rojas, Jesús Blázquez

❮ Previous
Next ❯

Citations

May 2, 2012·Antimicrobial Agents and Chemotherapy·C C PapagiannitsisL S Tzouvelekis
Dec 22, 2010·Antimicrobial Agents and Chemotherapy·Sébastien CoyneBruno Périchon
Mar 16, 2011·Antimicrobial Agents and Chemotherapy·Guo-Bao TianYohei Doi
Jun 19, 2012·Journal of Bacteriology·Laura E CuffEllen L Neidle
Dec 2, 2010·Microbiology and Molecular Biology Reviews : MMBR·Vanderlene L KungAlan R Hauser
Sep 14, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Maria S Ramirez, Marcelo E Tolmasky
Dec 17, 2015·Antimicrobial Agents and Chemotherapy·Grace A BlackwellRuth M Hall
Mar 7, 2014·Microbiology and Molecular Biology Reviews : MMBR·Elise Darmon, David R F Leach
Jun 27, 2014·Nature·Djalal Meziane-Cherif, Patrice Courvalin
Jan 22, 2020·The Journal of Antimicrobial Chemotherapy·Jennifer SchauerNiels Pfennigwerth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Antimicrobial Agents and Chemotherapy
Keith Poole
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Robert A Bonomo, Dora Szabo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
David M Livermore
© 2021 Meta ULC. All rights reserved